Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Neel Bhatt
+44 (0) 151 482 4700
neelbhatt@macplc.com


Dr Ashley Brooks
+44 (0) 161 274 1603
ashleybrooks@macplc.com


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Phase I Trial: Sponsor code: X11-201-00001

Phase I Trial: Sponsor code: X11-201-00001

Recruiting

Open to: All Genders

Age: Adult

Medical Conditions

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

27 Mar 2025 11 Jun 2026

Interventional

Intervention Type : Drug
Intervention Description : The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.




You can take part if:



You may not be able to take part if:


The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • MAC Clinical Research, Early Phase Unit
    Neuroscience Centre of Excellence Citilabs1.0, Nelson Street
    Manchester, Greater Manchester
    M13 9NQ
  • MAC Clinical Research Centre
    11 Tiger Court, King's Drive King's Business Park
    Prescot, Merseyside
    L34 1BH

This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.


The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc. and funded by Otsuka Pharmaceutical Development & Commercialization, Inc..




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN50440735
Last updated 31 March 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.